发明名称 FIBROIN-CONTAINING HYDROGELS FOR PELVIC TISSUE TREATMENT
摘要 The disclosure provides compositions, systems, and methods for the treatment of pelvic tissue conditions that include use of a silk fibroin-containing hydrogel composition. The composition includes water-soluble fibroin and a water-soluble crosslinkable polymer. The composition can be used as a pre-formed hydrogel or can be delivered to a pelvic tissue site and crosslinked in situ to form a hydrogel. The composition can be used to promote tissue closure, such as vaginal wound or fistula closure. The composition can also be used to enhance attachment or anchoring of a pelvic implant to a pelvic tissue. A hydrogel delivered to a pelvic tissue site, or formed at the site in situ, is associated with a portion of the implant (e.g., a mesh implant) via a tether or implant extension portion, thereby providing improved immobilization of the implant. Systems or kits that include the composition and a delivery needle or insertion tool are also described.
申请公布号 CA2894224(A1) 申请公布日期 2014.06.26
申请号 CA20132894224 申请日期 2013.12.20
申请人 AMS RESEARCH CORPORATION 发明人 MEYERING, EMILY R. ROLFES;ARCAND, BENJAMIN Y.
分类号 A61L27/22;A61F2/00;A61K35/12;A61L27/14;A61L27/52;A61P43/00 主分类号 A61L27/22
代理机构 代理人
主权项
地址